| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $31.12M | - | |
| CFO | 90.3K | $7.13M | - | |
| Other | 80.1K | $6.33M | - | |
| VP | 79.1K | $6.25M | - | |
| Other | 72.7K | $5.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Golden Lee Scott45 | EVP &Chief Medical Officer | Sell | 866 | $76.45 | $66,205.70 | -0.9% | -7.3% | - | |
| Jan 8, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 940 | $76.45 | $71,863.00 | -0.8% | -7.3% | - | |
| Jan 7, 2026 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 2,411 | $77.19 | $186,097.79 | -1.0% | -9.9% | - | |
| Jan 7, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 6,618 | $77.31 | $511,641.42 | -0.7% | -9.9% | - | |
| Jan 7, 2026 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 2,616 | $77.19 | $201,918.70 | -1.7% | -9.9% | - | |
| Jan 7, 2026 | Pauwels Eric62 | Chief Business Officer | Sell | 3,141 | $77.18 | $242,416.51 | -1.8% | -9.9% | - | |
| Jan 7, 2026 | Klein Matthew B.55 | Chief Executive Officer | Sell | 8,165 | $77.15 | $629,895.23 | -1.0% | -9.9% | - | |
| Jan 7, 2026 | Golden Lee Scott45 | EVP &Chief Medical Officer | Sell | 1,982 | $77.12 | $152,855.16 | -1.0% | -9.9% | - | |
| Jan 6, 2026 | Gravier Pierre55 | Chief Financial Officer | Sell | 2,139 | $76.95 | $164,596.05 | -2.3% | -10.2% | - | |
| Jan 5, 2026 | Boulding Mark Elliott55 | Exec. VP And CLO | Sale+OE | 2,266 | $75.55 | $171,191.98 | -0.6% | -10.2% | - |